人类表皮生长因子受体2-向治疗在上胃肠道癌症的进展
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hematology/oncology clinics of North America
|March 23, 2024
概括
特拉斯图祖马布改善了HER2阳性食道胃癌的治疗结果. 新的治疗方法,如T-DXd和组合治疗,对晚期疾病有很大的前景,扩大了治疗选择.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃癌特拉斯图祖马布 (Trastuzumab for Gastric Cancer,ToGA) 试验确定了特拉斯图祖马布用于治疗HER2阳性食道胃癌.
- KEYNOTE-811试验证明了免疫调节和HER2向之间的协同作用.
- 特拉斯图祖马布德鲁克斯泰干 (T-DXd) 为患有先进的HER2阳性疾病的患者提供了新的希望.
研究的目的:
- 审查对食道胃癌的HER2向治疗的历史成功和挑战.
- 探索当前的创新治疗策略和正在进行的临床试验.
- 突出新药在晚期HER2阳性食道胃癌中的潜力.
主要方法:
- 对关键临床试验的文献综述 (例如,ToGA,KEYNOTE-811).
- 分析新兴的治疗技术,包括抗体与药物结合物.
- 对正在进行的第一类和第一类人类药物的试验进行审查.
主要成果:
- 特拉斯图祖马布是治疗HER2阳性食道胃癌的基石疗法.
- 组合疗法和新药正在扩大治疗范式.
- 在先前的HER2向治疗中进展的患者中,T-DXd显示有效性.
结论:
- 针对HER2的治疗方法显著提升了食管胃癌的治疗方法.
- 对新型药物和组合的持续研究有望进一步改进.
- 个性化治疗策略对于管理先进的HER2阳性疾病至关重要.
更多相关视频
03:05Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.0K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
